3 Top Healthcare Stocks After #ASH18

3 Top Healthcare Stocks After #ASH18

The 60th annual American Society of Hematology (ASH) conference just wrapped up in San Diego and the high-profile conference didn’t disappoint. Many studies caught our eye at the conference, but data from three trials in particular stood-out for their potential to ignite investor optimism. In this episode of The Motley Fool’s Industry Focus: Healthcare, host […]

Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018

Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018

Long-awaited results proving two classes of cardiovascular disease drugs can reduce the risk of heart attack and stroke in 2018 could cause sales to soar for Amgen (NASDAQ: AMGN), Regeneron (NASDAQ: REGN), and Amarin Corp (NASDAQ: AMRN). In this clip from The Motley Fool’s Industry Focus: Healthcare, analyst Shannon Jones is joined by Todd Campbell to […]